Curable (XKRX:086460) EV-to-EBIT : (As of Jun. 25, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curable EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Curable's Enterprise Value is ₩21,913.5 Mil. Curable does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's EV-to-EBIT at this moment.

The historical rank and industry rank for Curable's EV-to-EBIT or its related term are showing as below:

XKRX:086460' s EV-to-EBIT Range Over the Past 10 Years
Min: -18.32 Med: -3.27 Max: 0.66
Current: -2.96

During the past 3 years, the highest EV-to-EBIT of Curable was 0.66. The lowest was -18.32. And the median was -3.27.

XKRX:086460's EV-to-EBIT is ranked worse than
100% of 101 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.28 vs XKRX:086460: -2.96

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Curable's Enterprise Value for the quarter that ended in Dec. 2023 was ₩28,998.6 Mil. Curable does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Curable's Earnings Yield (Joel Greenblatt) % at this moment.

Curable EV-to-EBIT Historical Data

The historical data trend for Curable's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curable EV-to-EBIT Chart

Curable Annual Data

Trend

Dec21

Dec22

Dec23

EV-to-EBIT

0.53

-23.26

-3.92

Curable Semi-Annual Data
	Dec21	Dec22	Dec23
EV-to-EBIT	-	-23.26	-3.92

Competitive Comparison of Curable's EV-to-EBIT

For the Diagnostics & Research subindustry, Curable's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curable's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Curable's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Curable's EV-to-EBIT falls into.

Curable EV-to-EBIT Calculation

Curable's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	21913.451	/
	=

Curable (XKRX:086460) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Curable's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=		/	28998.6421
	=	%

Curable EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Curable's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Curable (XKRX:086460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Curable Inc (XKRX:086460) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

93, Dongtan-daero 23-gil, 10th Floor, Gyeonggi-do, Hwaseong-si, KOR

Website

http://www.snp-genetics.com

Curable Inc provides genome analysis service.

Curable (XKRX:086460) Headlines

No Headlines